the 79.54122586136594
of 75.39171404689093
and 64.06054897043833
in 47.76329337410805
to 39.78524876656473
a 28.007943037716615
with 20.65368784913354
for 19.596879561671763
is 16.36589261977574
from 11.928710927624872
that 11.031382782874617
by 10.333909500509684
this 9.977602599388378
<doc> 9.933190407747198
</body> 9.933190407747198
</doc> 9.933190407747198
on 9.593033394495414
study 9.569817930682976
will 9.219567237512742
gene 8.73002376146789
were 8.72598628950051
genes 8.675517889908257
are 8.64422748216106
be 8.631105698267076
we 8.46859745158002
metagenomic 8.249564597349643
as 7.936660519877675
expression 7.824620672782875
patients 7.523829011213048
or 7.279561957186544
cardiovascular 6.427655372069317
was 6.006748919469929
data 5.969402303771662
an 5.925999480122324
species 5.857362456676861
human 5.754406921508664
disease 5.611076666666667
at 5.40213749235474
have 5.031699439347604
risk 4.736963985728848
these 4.319085637104995
blood 4.224205045871559
using 4.201998950050969
which 3.95470379204893
samples 3.809354801223242
: 3.7881580733944955
analysis 3.708418002038736
genetic 3.59738752293578
between 3.455066636085627
cells 3.442954220183486
cell 3.2663148216106013
treatment 3.0281039755351684
all 2.9857105198776757
into 2.9483639041794087
may 2.868623832823649
high 2.8090711213047914
has 2.7646589296636086
related 2.7636495616717633
not 2.6899656982670743
cancer 2.684918858307849
- 2.571869643221203
been 2.52543871559633
after 2.505251355759429
used 2.485063995922528
their 2.481026523955148
effects 2.4790077879714576
also 2.451754852191641
biological 2.449736116207951
associated 2.4093613965341487
species. 2.396239612640163
sample 2.382108460754332
such 2.3689866768603465
including 2.34173374108053
two 2.292274709480122
can 2.2801622935779817
clinical 2.2771341896024464
2 2.2751154536187568
type 2.274106085626911
distal 2.2670405096839956
each 2.1893191743119265
other 2.0843449031600407
it 2.0823261671763507
heart 2.051035759429154
identified 2.0126797757390418
3 2.001576727828746
number 1.979370632008155
one 1.9712956880733945
group 1.9712956880733945
highly 1.9692769520897044
new 1.9531270642201835
health 1.9188085524974516
different 1.908714872579001
changes 1.9016492966360856
more 1.8885275127421
they 1.8774244648318044
important 1.8663214169215088
overall 1.855218369011213
no 1.838059113149847
studies 1.8370497451580021
genome 1.8350310091743118
factors 1.818881121304791
subjects 1.7754782976554537
levels 1.7754782976554537
during 1.7704314576962283
control 1.7603377777777778
range 1.7532722018348623
rna 1.7340942099898065
effect 1.7229911620795109
first 1.7189536901121303
sequencing 1.7088600101936797
compared 1.677569602446483
diabetes 1.6735321304791029
design: 1.657382242609582
gut 1.6513260346585117
bacterial 1.6432510907237512
mice 1.6260918348623852
who 1.6028763710499492
our 1.5877358511722732
microbiota 1.5786515392456675
than 1.567548491335372
determine 1.5554360754332315
identify 1.550389235474006
both 1.5372674515800202
but 1.5201081957186544
displays 1.513042619775739
plasmids, 1.4999208358817533
function 1.4918458919469928
(metahit), 1.4817522120285422
microarray 1.473677268093782
quality 1.4645929561671762
present 1.4474337003058104
investigators 1.4464243323139654
dna 1.4433962283384303
protein 1.4433962283384303
increased 1.4211901325178389
response 1.4171526605504587
genomic 1.4121058205912336
large 1.402012140672783
development 1.3929278287461773
three 1.3818247808358817
metabolic 1.3787966768603466
primary 1.3707217329255863
global 1.3575999490316004
therapy 1.3555812130479103
show 1.3434687971457697
most 1.3374125891946993
any 1.3364032212028543
tissue 1.335393853211009
1 1.3303470132517838
there 1.3202533333333333
results 1.3162158613659531
performed 1.3152064933741079
total 1.313187757390418
healthy 1.3041034454638123
well 1.3030940774719675
whether 1.3000659734964322
chronic 1.2919910295616719
research 1.2586818858307849
participants 1.2566631498470948
use 1.2475788379204893
evaluate 1.2395038939857288
genes, 1.2384945259938838
previously 1.225372742099898
low 1.2213352701325177
tumor 1.2122509582059122
role 1.2102322222222224
purpose 1.208213486238532
through 1.207204118246687
* 1.206194750254842
complex 1.1950917023445462
database 1.1940823343527014
search 1.190044862385321
sequence 1.188026126401631
coronary 1.1769230784913354
information 1.1718762385321102
derived 1.1718762385321102
if 1.168848134556575
variation 1.1638012945973497
disease. 1.1597638226299694
expressed 1.1526982466870541
profiling 1.1446233027522936
exercise 1.132510886850153
specific 1.1284734148827726
normal 1.099201743119266
insulin 1.097183007135576
diet 1.0951642711518859
molecular 1.0880986952089704
diseases 1.0780050152905198
mouse 1.0739675433231397
its 1.0719488073394494
among 1.0669019673802242
vascular 1.0658925993883792
liver 1.0568082874617737
based 1.0477239755351682
known 1.0477239755351682
functions 1.0416677675840977
involved 1.0386396636085629
found 1.0376302956167176
about 1.0346021916411823
however, 1.0325834556574924
enriched 1.025517879714577
even 1.023499143730887
trial 1.0174429357798165
series 1.0154241997961264
structure 0.9871618960244648
wide 0.9871618960244648
intervention 0.9831244240570847
strong 0.9811056880733946
syndrome 0.9730307441386341
test 0.9669745361875637
size 0.9659651681957186
peripheral 0.9599089602446483
over 0.9568808562691131
level 0.9558714882772681
those 0.9467871763506626
body 0.9457778083588175
represent 0.9447684403669725
several 0.9417403363914374
interactions 0.9407309683995922
profiles 0.937702864424057
whole 0.9336653924566769
time 0.9336653924566769
endothelial 0.9286185524974516
only 0.9265998165137616
deep 0.9255904485219164
individuals 0.9225623445463812
available 0.9195342405708461
women 0.9185248725790011
significant 0.9165061365953109
across 0.9124686646279306
million 0.9043937206931703
proportion 0.901365616717635
cardiac 0.90035624872579
novel 0.899346880733945
provide 0.8983375127420998
some 0.8963187767584098
sequenced 0.8953094087665647
major 0.8902625688073394
factor 0.8892532008154944
abundance 0.8882438328236493
cholesterol 0.8852157288481142
fat 0.8811782568807339
potential 0.8801688888888889
4 0.8761314169215086
6 0.8751220489296636
species, 0.8741126809378186
lung 0.8700752089704383
following 0.8670471049949032
breast 0.8660377370030581
concept 0.8620002650356778
transcriptome 0.8599815290519878
genomes 0.8589721610601427
many 0.8569534250764526
aim 0.8569534250764526
types 0.8569534250764526
unknown 0.8559440570846075
population 0.8539253211009175
system 0.8508972171253822
assess 0.8508972171253822
early 0.8498878491335372
activity 0.8498878491335372
microbial 0.846859745158002
muscle 0.8448410091743119
pressure 0.8438316411824668
without 0.8418129051987767
common 0.8397941692150866
lipid 0.8397941692150866
acquired 0.8397941692150866
age 0.8377754332313966
stress 0.8377754332313966
physical 0.8337379612640162
patient 0.8337379612640162
characteristic 0.8337379612640162
treated 0.8307098572884812
drug 0.828691121304791
years 0.8266723853211009
when 0.8256630173292558
similarity 0.8135506014271152
gc 0.8125412334352702
acute 0.8085037614678899
care 0.8085037614678899
applying 0.8074943934760448
typically 0.8074943934760448
islands 0.8064850254841998
functional 0.8044662895005097
smaller 0.8044662895005097
clonal 0.7974007135575942
methylation 0.7963913455657493
apparent 0.7953819775739042
criteria. 0.791344505606524
model 0.7873070336391437
immune 0.7862976656472987
acid 0.7862976656472987
differentially 0.7832695616717635
receptor 0.7822601936799184
within 0.7802414576962283
how 0.7802414576962283
improve 0.7802414576962283
kidney 0.7792320897043833
complex, 0.7762039857288482
content. 0.7762039857288482
cause 0.775194617737003
unsupervised 0.773175881753313
increase 0.7721665137614678
remarkable 0.7721665137614678
safety 0.7711571457696228
medical 0.7701477777777778
draft 0.7701477777777778
strategy, 0.7691384097859327
consistency 0.7681290417940877
biotic 0.7681290417940877
investigate 0.7671196738022426
resembling 0.7640915698267075
dominated 0.7630822018348624
catalogue 0.7630822018348624
lacks 0.7620728338430174
pass 0.7620728338430174
organism. 0.7610634658511722
bacteria, 0.7610634658511722
further 0.7600540978593272
phages 0.7600540978593272
stool 0.7590447298674822
taxonomy 0.7570259938837921
islands, 0.756016625891947
assemblies 0.756016625891947
genomes, 0.7539978899082569
396 0.7539978899082569
growth 0.7529885219164119
gut. 0.7529885219164119
741 0.7519791539245668
structuring 0.7519791539245668
entities, 0.7519791539245668
immensely 0.7509697859327217
entities: 0.7509697859327217
3.9 0.7509697859327217
bacteriophages 0.7509697859327217
dependencies 0.7509697859327217
gene-rich 0.7509697859327217
differences 0.7499604179408766
co-variance 0.7499604179408766
co-varying 0.7499604179408766
bacteriophages. 0.7499604179408766
7,381 0.7499604179408766
6,319 0.7499604179408766
contained. 0.7499604179408766
meta-genomic 0.7499604179408766
247 0.7499604179408766
hmp 0.7499604179408766
(73%) 0.7499604179408766
interdependencies 0.7499604179408766
artery 0.7459229459734964
markers 0.7459229459734964
weeks 0.7439042099898063
obtained 0.7439042099898063
dose 0.7428948419979612
project 0.7338105300713558
brain 0.7328011620795106
before 0.7277543221202853
phase 0.7257355861365953
could 0.7237168501529052
pathways 0.7216981141692151
set 0.7186700101936799
events 0.7166512742099899
target 0.7126138022426096
profile 0.7116044342507645
collected 0.7105950662589194
fatty 0.7085763302752294
individual 0.7075669622833843
association 0.7055482262996942
per 0.7035294903160041
single 0.7015107543323139
people 0.700501386340469
small 0.6994920183486238
four 0.6974732823649338
stem 0.6974732823649338
shown 0.6964639143730886
patients. 0.6954545463812437
10 0.6944451783893986
cells. 0.6893983384301733
cohort 0.6793046585117227
disease, 0.6793046585117227
significantly 0.6772859225280327
study. 0.6752671865443425
metabolism 0.6752671865443425
plasma 0.6732484505606524
bone 0.6712297145769622
5 0.6651735066258919
renal 0.6651735066258919
transcription 0.6611360346585118
then 0.6611360346585118
part 0.6611360346585118
reduce 0.6611360346585118
family 0.6581079306829766
evidence 0.6581079306829766
while 0.6530610907237513
mechanisms 0.6510423547400612
days 0.6500329867482161
compare 0.6470048827726809
children 0.6449861467889908
study, 0.6419580428134556
groups 0.6419580428134556
12 0.6409486748216107
efficacy 0.6379205708460755
history 0.6359018348623854
inflammatory 0.6348924668705402
dietary 0.6328737308868502
obesity 0.631864362895005
impact 0.6288362589194699
weight 0.6268175229357797
same 0.6258081549439348
multiple 0.6258081549439348
rate 0.6227800509683996
months 0.6207613149847095
cases 0.6167238430173293
had 0.6136957390417941
either 0.611677003058104
combination 0.6106676350662589
include 0.6066301630988787
program 0.6066301630988787
standard 0.6025926911314985
showed 0.6025926911314985
effective 0.5985552191641182
hypothesis 0.5924990112130478
receive 0.5924990112130478
genes. 0.5844240672782876
examine 0.5813959633027523
patterns 0.5803865953109072
array 0.5803865953109072
life 0.5783678593272171
higher 0.5763491233435271
randomized 0.5733210193679918
na 0.5723116513761468
glucose 0.5713022833843018
national 0.5692835474006116
inflammation 0.5672648114169215
vitamin 0.5652460754332314
transcriptional 0.5652460754332314
[ 0.5642367074413863
resistance 0.5612086034658511
due 0.557171131498471
serum 0.5541430275229358
tumors 0.5541430275229358
analyzed 0.5531336595310907
analyses 0.5521242915392457
lipoprotein 0.5490961875637105
myocardial 0.5470774515800204
genome-wide 0.5460680835881753
controls 0.5460680835881753
adult 0.5430399796126402
sapiens 0.54102124362895
obese 0.5400118756371051
diabetic 0.5379931396534149
day 0.5369837716615699
identification 0.5339556676860346
loss 0.5319369317023446
out 0.5309275637104994
under 0.5299181957186545
regulation 0.5289088277268094
stage 0.521843251783894
tissues 0.521843251783894
designed 0.5198245158002038
revealed 0.5198245158002038
order 0.5188151478083588
additional 0.5188151478083588
given 0.5167964118246687
affymetrix 0.5157870438328237
mutations 0.5127589398572885
least 0.5117495718654435
isolated 0.5107402038735984
proteins 0.5097308358817533
mortality 0.5077120998980632
8 0.504683995922528
atherosclerosis 0.503674627930683
training 0.5026652599388379
help 0.5026652599388379
prevention 0.5016558919469928
versus 0.5006465239551479
homo 0.4996371559633027
daily 0.4996371559633027
up 0.49761841997961265
suggest 0.49459031600407743
selected 0.4935809480122324
induced 0.4935809480122324
measured 0.49257158002038737
conducted 0.49156221202854233
objective 0.48550600407747196
surgery 0.4844966360856269
progression 0.4824779001019368
mrna 0.4824779001019368
reduction 0.4804591641182467
hypertension 0.47944979612640165
and/or 0.47944979612640165
arterial 0.4774310601427115
ii 0.4754123241590214
included 0.4754123241590214
comparison 0.47440295616717637
cvd 0.47440295616717637
outcomes 0.47238422018348625
secondary 0.4703654841997961
being 0.46834674821610606
lower 0.4643092762487258
sleep 0.4643092762487258
death 0.4632999082568808